ATAI Life Sciences N.V. - Common Shares (NQ: ATAI )
2.300
+0.030
(+1.32%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about ATAI Life Sciences N.V. - Common Shares
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_17.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_16.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_15.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_14.png?width=720)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_12.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_11.png?width=720)
Psychedelic Stock Gainers And Losers From February 17, 2022
February 17, 2022
Via Benzinga
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_9.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_8.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_15.jpg?width=720)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_7.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_551.png)
![](https://cdn.benzinga.com/files/images/story/2012/souvik-banerjee-9z-2ktg6cim-unsplash_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_5.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mandalas-1084082_1920.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_4.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/photo-1529059356407-0114ed24b913.jpeg?width=1200&height=800&fit=crop)
Is The Psychedelics Sector In Decline? This $30M VC Fund Says HOLD
February 07, 2022
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/dsc06532_6.jpg?width=1200&height=800&fit=crop)
![](/images/schema-image-default.png)
![](/images/schema-image-default.png)
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_brain-4866447_640_637529062347141906.png)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.